Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma

BJU International

Volumn 94, Issue 4, 2004, Pages 544-547

  Mai, Kien T ^a,b   Elmontaser, Ghazi ^a   Perkins, D Garth ^a   Yazdi, Hossein M ^a   Stinson, William A ^a   Thijssen, Anthony ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Invasive; Low grade; Low malignant potential; Papillary; Urothelial carcinoma

Indexed keywords

CYTOKERATIN 20; KI 67 ANTIGEN; PROTEIN P53; UVOMORULIN;

ADULT; AGED; BLADDER BIOPSY; BLADDER TUMOR; CANCER GRADING; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DEMOGRAPHY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; MALE; PAPILLOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVIEW; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UROGENITAL TRACT TUMOR;

AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SARCOMA; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 4544305508     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-4096.2004.04923.x     Document Type: Review

References (18)

1. Epstein JI, Amin MB, Reuter VR. The World Health Organization/ International Society of Urological Pathology Consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435-48
2. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder: can biologic potential be predicted from histological grading? Cancer 1987; 60: 2766-74
3. Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 2002; 60: 315-9
4. Pich A, Chiusa L, Formiconi A et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002; 95: 784-90
5. Cina SJ, Lancaster-Weiss KJ, Lecksell K. Correlation of Ki-67 and P53 with the New World Health Organization 2001, International Society of Urological Pathology Classification System for urothelial neoplasia. Arch Pathol Laboratory Medical 2001; 125: 646-51
6. Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/International Society of Urologic Pathology. Mod Pathol 2001; 14: 267-72
7. Desai S, Lim SD, Jiminez RE et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol 2000; 13: 1315-23
8. Harnden P, Mahmood N, Southgate J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999; 353: 974-7
9. Young RH, Zukerberg LR. Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 1991; 96: 635-9
10. Young RH, Eble JN. Unusual forms of carcinoma of the urinary bladder. Hum Pathol 1991; 22: 948-65
11. Talbert ML, Young RH. Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases. Am J Surg Pathol 1989; 13: 374-81
12. Murphy WM, Deana DG. The nested variant of transitional cell carcinoma. A neoplasm resembling proliferation of Brunn's nests. Mod Pathol 1992; 5: 240
13. Sun W, Herrera GA. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. Hum Pathol 2002; 33: 996-1000
14. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-8
15. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999; 154: 721-7
16. Baithun SI, Naase M, Blanes A, Diaz-Cano SJ. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications. Virchows Arch 2001; 438: 289-97
17. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Laboratory Invest 2000; 80: 279-89
18. Aaltonen V, Bostrom PJ, Soderstrom KO et al. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Am J Pathol 1999; 154: 755-65